An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2017
published in
has subject area
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
- Cross-Sectional Studies
- Delivery of Health Care
- Drug Utilization
- Female
- Health Services Research
- Humans
- Insurance, Health, Reimbursement
- Male
- Medicare Part B
- Ophthalmologists
- Ranibizumab
- Receptors, Vascular Endothelial Growth Factor
- Recombinant Fusion Proteins
- Retrospective Studies
- United States
- Vascular Endothelial Growth Factor A